Abstract:There is a growing concern that neuroactive chemicals released into the environment can perturb wildlife behaviour. Among these chemicals, pharmaceuticals such as antidepressants and anxiolytics have been receiving increasing attention, as they are specifically prescribed to modify behavioural responses. Many laboratory studies have demonstrated that some of these compounds can affect various aspects of the behaviour of a range of aquatic organisms; however, these investigations are focused on a very small set of neuroactive pharmaceuticals, and they often consider one compound at a time. In this study, to better understand the environmental and toxicological dimension of the problem, we considered all pharmaceuticals explicitly intended to modulate the central nervous system (CNS), and we hypothesised that these compounds have higher probability of perturbing animal behaviour. Based on this hypothesis, we used the classification of pharmaceuticals provided by the British National Formulary (based on their clinical applications) and identified 210 different CNS-acting pharmaceuticals prescribed in the UK to treat a variety of CNS-related conditions, including mental health and sleep disorders, dementia, epilepsy, nausea, and pain. The analysis of existing databases revealed that 84 of these compounds were already detected in surface waters worldwide. Using a biological read-across approach based on the extrapolation of clinical data, we predicted that the concentration of 32 of these neuroactive pharmaceuticals in surface waters in England may be high enough to elicit pharmacological effects in wild fish. The ecotoxicological effects of the vast majority of these compounds are currently uncharacterised. Overall, these results highlight the importance of addressing this environmental challenge from a mixture toxicology and systems perspective. The knowledge platform developed in the present study can guide future region-specific prioritisation efforts, inform the design of mixture studies, and foster interdisciplinary efforts aimed at identifying novel approaches to predict and interpret the ecological implications of chemical-induced behaviour disruption.

Factors Determining the Susceptibility of Fish to Effects of Human Pharmaceuticals

Risks to aquatic environments posed by 14 pharmaceuticals as illustrated by their effects on zebrafish behaviour

Fate and occurrence of pharmaceuticals in the aquatic environment (surface water and sediment)

Developing an Approach for Integrating Chemical Analysis and Transcriptional Changes to Assess Contaminants in Water, Sediment, and Fish

Bioaccumulation and biomagnification potential of pharmaceuticals with a focus to the aquatic environment

Environmental Occurrence and Predicted Pharmacological Risk to Freshwater Fish of over 200 Neuroactive Pharmaceuticals in Widespread Use

Human pharmaceuticals in the marine environment: Focus on exposure and biological effects in animal species

Pharmaceuticals in Water: Risks to Aquatic Life and Remediation Strategies

Assessment of wastewater-borne pharmaceuticals in tissues and body fluids from riverine fish

The impact of pharmaceutical pollutants on daphnids - A metabolomic approach

Freshwater crustacean exposed to active pharmaceutical ingredients: ecotoxicological effects and mechanisms

Toxicity of selected pharmaceuticals and their mixtures to the aquatic indicators Daphnia magna and Aliivibrio fischeri

[Pharmaceutical residues in aquatic compartments : Status quo and perspectives]

Toxicity Prediction and Effect Characterization of 90 Pharmaceuticals and Illicit Drugs Measured in Plasma of Fish from a Major European River (sava, Croatia)

Determination of the pharmaceuticals-nano/microplastics in aquatic systems by analytical and instrumental methods

The risk of pharmaceuticals in the aquatic environment By

A review of the effects of pharmaceutical pollutants on humans and aquatic ecosystem

Pharmaceuticals in biota: The impact of wastewater treatment plant effluents on fish in Australia

Comparative Pharmaceutical Metabolism by Rainbow Trout (oncorhynchus Mykiss) Liver S9 Fractions

Defining the data gap: what do we know about environmental exposure, hazards and risks of pharmaceuticals in the European aquatic environment?

Exposure to wastewater effluent affects fish behaviour and tissue-specific uptake of pharmaceuticals